Mind Medicine to begin trading on Nasdaq today

Apr 27, 2021

2021-04-27 09:22 ET – News Release

An anonymous director reports

MINDMED BEGINS TRADING ON NASDAQ

Mind Medicine (MindMed) Inc. has started trading on the Nasdaq Capital Market. Trading will begin on Tuesday, April 27, 2021, under the symbol MNMD on the Nasdaq.

As a reminder, MindMed will retain its listing on the Neo Exchange under the symbol MMED. Once trading begins, the company’s subordinate voting shares will convert from the OTCQB under the symbol MMEDF to the new symbol MNMD.

Furthermore, there will be a live bell ringing ceremony for MindMed on Thursday during the opening bell.

About Mind Medicine (MindMed) Inc

MindMed is a clinical-stage psychedelic medicine biotech company that discovers, develops and deploys psychedelic-inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including psilocybin, LSD, MDMA, DMT and an ibogaine derivative, 18-MC. The MindMed executive team brings extensive biopharmaceutical experience to MindMed’s approach to developing the next generation of psychedelic-inspired medicines and therapies.

We seek Safe Harbor.

https://mindmed.co/